When the FDA escalates, we respond with you.
Confidential FDA 483 and Warning Letter response for biopharma, medical-device, and gene & cell therapy manufacturers. 500+ regulatory inspections — flawless record. Senior practitioners on every engagement. First call is free.
(919) 351-6541Request a Confidential Consultation
Takes 60 seconds 100% confidential
Request Received
Thank you. A senior advisor will contact you within one business day. Your information is held in strict confidence.
Trusted by life-sciences manufacturers that can’t afford to fail an FDA inspection.
Why quality & regulatory leaders pick LaSalle
Senior practitioners — not junior staff — on every engagement. Fast, confidential, and written to survive the follow-up inspection.
FDA + 12 Other Regulators
Our senior consultants have shepherded submissions through the FDA and twelve other global regulatory bodies across 35+ years in life-sciences operations.
Integrated, Not Siloed
Quality and regulatory rarely live alone. Our consultants cover operations, transformation, and people alongside — so a 483 response also stabilizes the system that produced it.
No Cookie-Cutter Engagements
Every project is a personalized plan. 97% of our transformations hold up over time — versus the industry average of 70% that don't.
Got an FDA letter on your desk?
Call now for a confidential first conversation — or scroll up and request one in under a minute.
(919) 351-6541 or Fill out the form above